Center of Innovation for Complex Chronic Healthcare, Department of Veterans Affairs, Edward Hines Jr VA Hospital, Hines, IL.
Center of Innovation for Complex Chronic Healthcare, Department of Veterans Affairs, Edward Hines Jr VA Hospital, Hines, IL; College of Pharmacy, Department of Pharmacy, Systems, Outcomes, and Policy, University of Illinois-Chicago, Chicago, IL.
Am J Infect Control. 2017 Nov 1;45(11):1183-1189. doi: 10.1016/j.ajic.2017.06.016. Epub 2017 Jul 27.
Multidrug-resistant (MDR) Acinetobacter is a growing concern and has been identified as a serious threat by the Centers for Disease Control and Prevention. However, there is little information on MDR Acinetobacter in individuals with spinal cord injuries and disorders (SCI/Ds). Therefore, the objective of this study was to identify risk factors for, and assess outcomes of, MDR Acinetobacter in veterans with SCI/Ds.
This was a retrospective cohort study from January 1, 2012-December 31, 2013, using national Veterans Affairs medical encounter and microbiology data.
A total of 773 Acinetobacter cultures were identified in 571 patients, of which 58.9% were MDR. Inpatient culture, sputum and other specimen type, receipt of antibiotics within 90 days before culture date, and pressure ulcers were identified as independent predictors of MDR Acinetobacter. Highest odds of MDR Acinetobacter were seen with previous antibiotic use (odds ratio, 7.27; 95% confidence interval, 2.59-20.54). Thirty-day mortality was 5.3% in this study. Multidrug resistance, previous mechanical ventilation 90 days before the culture, and cancer were all independent risk factors for 30-day mortality.
There should be increased efforts to highlight the importance of antimicrobial stewardship to improve infection control to help limit spread of Acinetobacter in health care settings.
耐多药(MDR)不动杆菌日益受到关注,已被疾病控制与预防中心确认为严重威胁。然而,有关脊髓损伤和疾病(SCI/D)患者中 MDR 不动杆菌的信息却很少。因此,本研究旨在确定 SCI/D 退伍军人中 MDR 不动杆菌的危险因素,并评估其结果。
这是一项回顾性队列研究,研究时间为 2012 年 1 月 1 日至 2013 年 12 月 31 日,使用了全国退伍军人事务部的医疗就诊和微生物学数据。
在 571 名患者中鉴定出了 773 株不动杆菌培养物,其中 58.9%为 MDR。住院患者的培养物、痰和其他标本类型、在培养日期前 90 天内接受抗生素治疗以及压疮被确定为 MDR 不动杆菌的独立预测因素。既往抗生素使用的可能性最高(优势比,7.27;95%置信区间,2.59-20.54)。在这项研究中,30 天的死亡率为 5.3%。MDR、培养前 90 天的机械通气和癌症均是 30 天死亡率的独立危险因素。
应加大努力强调抗菌药物管理的重要性,以改善感染控制,有助于限制不动杆菌在医疗机构中的传播。